Evidence map›Paper›PMID 37002212›Full record

ArticleNature communications2023

Inhibitor-3 inhibits Protein Phosphatase 1 via a metal binding dynamic protein-protein interaction.

Gautam Srivastava, Meng S Choy, Nicolas Bolik-Coulon, Rebecca Page, Wolfgang Peti

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Fuzziness in enzymatic catalysis.Current opinion in structural biology · 2025
    Review
  4. Review
  5. Article
  6. Review
  7. How proteins sense their cellular environment.Nature reviews. Molecular cell biology · 2025
    Article
  8. Article
  9. Article
  10. Review
  11. A protein phosphatase 1 specificProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  12. Review
  13. Alternating binding and p97-mediated dissociation of SDS22 and I3 recycles active PP1 between holophosphatases.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Gautam SrivastavaDepartment of Molecular Biology and Biophysics, University of Connecticut Health Center, Farmington, CT, USA.ORCID 0000-0002-8703-8903
Meng S ChoyDepartment of Molecular Biology and Biophysics, University of Connecticut Health Center, Farmington, CT, USA.
Nicolas Bolik-CoulonDepartment of Chemistry and Biochemistry, University of Arizona, Tucson, AZ, USA.
Rebecca PageDepartment of Cell Biology, University of Connecticut Health Center, Farmington, CT, USA.
Wolfgang PetiDepartment of Molecular Biology and Biophysics, University of Connecticut Health Center, Farmington, CT, USA. peti@uchc.edu.ORCID 0000-0002-8830-6594
UConn Health · USUniversity of Arizona · US

Funding

The Regulation of PP1 in the NucleusR01GM098482 · NIGMS · UNIVERSITY OF ARIZONA · PI PAGE, REBECCA · 2011 to 2019
$2.8M
Serine/Threonine Phosphatases in Neurological DiseasesR01NS124666 · NINDS · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI Wolfgang Peti · 2023 to 2026
$2.0M
Protein Phosphatase 1 Holoenzyme FormationR01GM144483 · NIGMS · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI PETI, WOLFGANG · 2022 to 2025
$1.7M
NIGMS NIH HHS R01 GM098482NIGMS NIH HHS R01 GM144483NINDS NIH HHS R01 NS124666
6 · The paper itself

Abstract

To achieve substrate specificity, protein phosphate 1 (PP1) forms holoenzymes with hundreds of regulatory and inhibitory proteins. Inhibitor-3 (I3) is an ancient inhibitor of PP1 with putative roles in PP1 maturation and the regulation of PP1 activity. Here, we show that I3 residues 27-68 are necessary and sufficient for PP1 binding and inhibition. In addition to a canonical RVxF motif, which is shared by nearly all PP1 regulators and inhibitors, and a non-canonical SILK motif, I3 also binds PP1 via multiple basic residues that bind directly in the PP1 acidic substrate binding groove, an interaction that provides a blueprint for how substrates bind this groove for dephosphorylation. Unexpectedly, this interaction positions a CCC (cys-cys-cys) motif to bind directly across the PP1 active site. Using biophysical and inhibition assays, we show that the I3 CCC motif binds and inhibits PP1 in an unexpected dynamic, fuzzy manner, via transient engagement of the PP1 active site metals. Together, these data not only provide fundamental insights into the mechanisms by which IDP protein regulators of PP1 achieve inhibition, but also shows that fuzzy interactions between IDPs and their folded binding partners, in addition to enhancing binding affinity, can also directly regulate enzyme activity.

Indexed as

Protein Processing, Post-TranslationalProteinsBinding SitesCatalytic DomainPhosphorylationProtein BindingProtein Phosphatase 1Protein Phosphatase 1Proteins

Identifiers

PMID37002212
PMCPMC10066265
OpenAlexW4362472780

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.